ID

13021

Description

Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00275015

Link

https://clinicaltrials.gov/show/NCT00275015

Keywords

Versions (1)
  1. 1/12/16 1/12/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

January 12, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Leukemia NCT00275015

English

Eligibility Leukemia NCT00275015

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00275015
Criteria
Description

Criteria

patients with chronic lymphocytic leukemia, meeting 1 of the following criteria:
Description

CLL

Data type

boolean

Alias
UMLS CUI [1]
C0023434
binet stage b or c disease
Description

binet stage

Data type

boolean

Alias
UMLS CUI [1]
C1511118
binet stage a disease and at high risk for disease progression, defined as the following:
Description

binet stage a disease and at high risk for disease progression

Data type

boolean

Alias
UMLS CUI [1]
C1511118
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
Description

non-nodular marrow infiltration or lymphocyte doubling time < 12 months

Data type

boolean

Alias
UMLS CUI [1]
C3854434
UMLS CUI [2]
C2986483
thymidine kinase > 7.0 u/l or ß-2-microglobulin > 3.5 mg/l
Description

thymidine kinase, ß-2-microglobulin

Data type

boolean

Alias
UMLS CUI [1]
C0040078
UMLS CUI [2]
C0005149
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
Description

polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h

Data type

boolean

Alias
UMLS CUI [1]
C0887928
ecog performance status 0-1
Description

ecog performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
no concurrent disease resulting in major organ dysfunction
Description

no concurrent disease resulting in major organ dysfunction

Data type

boolean

Alias
UMLS CUI [1]
C0009488
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
Description

no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)

Data type

boolean

Alias
UMLS CUI [1]
C0025241
UMLS CUI [2]
C0011777
UMLS CUI [3]
C0007257
UMLS CUI [4]
C0010711
UMLS CUI [5]
C0015133
no more than 1 prior chemotherapy regimen
Description

no more than 1 prior chemotherapy regimen

Data type

boolean

Alias
UMLS CUI [1]
C0392920
no prior chemotherapy regimen longer than 6 months in duration
Description

no prior chemotherapy regimen longer than 6 months in duration

Data type

boolean

Alias
UMLS CUI [1]
C0392920
Back to the top of the page

Similar models

Eligibility Leukemia NCT00275015

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00275015
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
CLL
Item
patients with chronic lymphocytic leukemia, meeting 1 of the following criteria:
boolean
C0023434 (UMLS CUI [1])
binet stage
Item
binet stage b or c disease
boolean
C1511118 (UMLS CUI [1])
binet stage a disease and at high risk for disease progression
Item
binet stage a disease and at high risk for disease progression, defined as the following:
boolean
C1511118 (UMLS CUI [1])
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
Item
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
boolean
C3854434 (UMLS CUI [1])
C2986483 (UMLS CUI [2])
thymidine kinase, ß-2-microglobulin
Item
thymidine kinase > 7.0 u/l or ß-2-microglobulin > 3.5 mg/l
boolean
C0040078 (UMLS CUI [1])
C0005149 (UMLS CUI [2])
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
Item
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
boolean
C0887928 (UMLS CUI [1])
ecog performance status
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
no concurrent disease resulting in major organ dysfunction
Item
no concurrent disease resulting in major organ dysfunction
boolean
C0009488 (UMLS CUI [1])
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
Item
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
boolean
C0025241 (UMLS CUI [1])
C0011777 (UMLS CUI [2])
C0007257 (UMLS CUI [3])
C0010711 (UMLS CUI [4])
C0015133 (UMLS CUI [5])
no more than 1 prior chemotherapy regimen
Item
no more than 1 prior chemotherapy regimen
boolean
C0392920 (UMLS CUI [1])
no prior chemotherapy regimen longer than 6 months in duration
Item
no prior chemotherapy regimen longer than 6 months in duration
boolean
C0392920 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial